EP Patent

EP2429295B1 — Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof

Assigned to Curia Global Inc · Expires 2013-12-25 · 12y expired

What this patent protects

Novel aryl, heteroaryl, and non-aromatic heterocyle substituted tetrahydroisoquinolines are described in the present invention. These compounds are used in the treatment of various neurological and physiological disorders. Methods of making these compounds are also described in t…

USPTO Abstract

Novel aryl, heteroaryl, and non-aromatic heterocyle substituted tetrahydroisoquinolines are described in the present invention. These compounds are used in the treatment of various neurological and physiological disorders. Methods of making these compounds are also described in the present invention.

Drugs covered by this patent

Patent Metadata

Patent number
EP2429295B1
Jurisdiction
EP
Classification
—
Expires
2013-12-25
Drug substance claim
No
Drug product claim
No
Assignee
Curia Global Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.